A recent study showed that patient-derived xenograft (PDX) PDACs expressed targetable levels of HER2 by HER2.CARTs, and they also found that PDAC cancer-stem cells (CSCs) express similar levels of HER2 as the non-CSC population40. The gene discussed is ERBB2; the disease is cancer.